FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2084009328> ?p ?o ?g. }

• W2084009328 endingPage "883" @default.
• W2084009328 startingPage "878" @default.
• W2084009328 abstract "Several multicomponent regimens have been reported to be useful in advanced androgen-independent prostate cancer. We used a randomized phase II design to evaluate and compare two such regimens. Patients were accrued primarily in the community setting.Patients with progressive, androgen-independent prostate cancer were randomly assigned to one of two treatments: either ketoconazole/doxorubicin alternating with vinblastine/estramustine (KA/VE) or paclitaxel, estramustine, and oral etoposide (TEE). Patients were prospectively stratified on the basis of disease volume. The primary end points were response and overall survival time.A total of 75 patients were registered; 71 are included in the analysis. By the criterion of an 80% prostate-specific antigen reduction maintained for at least 8 weeks, 11 (30%) of 37 patients in the TEE arm responded, whereas 11 (32%) of 34 assigned to KA/VE responded. Median survival was 16.9 months (95% confidence interval [CI], 10.5 to 21.2 months) in the TEE arm and 23.4 months (95% CI, 12.9 to 30.6 months) for patients treated with KA/VE. Many patients (24%) failed to complete at least 6 weeks of therapy, including five (8%) treatment-related early deaths.Each of these regimens produced clinically significant responses, and the observed median survival (18.9 months for all 71 patients) compares favorably with previously published results, especially in the community setting. Nonetheless, it is apparent that these first-generation regimens must be applied judiciously, and thus we view efforts at better patient selection and the development of more tolerable therapies as higher priorities than carrying either of these regimens to phase III evaluation in the cooperative group setting." @default.
• W2084009328 created "2016-06-24" @default.
• W2084009328 creator A5002347804 @default.
• W2084009328 creator A5006101210 @default.
• W2084009328 creator A5008820123 @default.
• W2084009328 creator A5009102500 @default.
• W2084009328 creator A5027897588 @default.
• W2084009328 creator A5045807201 @default.
• W2084009328 creator A5066408904 @default.
• W2084009328 creator A5079982147 @default.
• W2084009328 date "2003-03-01" @default.
• W2084009328 modified "2023-10-14" @default.
• W2084009328 title "Randomized, Multicenter, Phase II Trial of Two Multicomponent Regimens in Androgen-Independent Prostate Cancer" @default.
• W2084009328 cites W1905912155 @default.
• W2084009328 cites W1966714873 @default.
• W2084009328 cites W1984749582 @default.
• W2084009328 cites W2024081693 @default.
• W2084009328 cites W2029409133 @default.
• W2084009328 cites W2058120885 @default.
• W2084009328 cites W2069950565 @default.
• W2084009328 cites W2087039456 @default.
• W2084009328 cites W2093333853 @default.
• W2084009328 cites W2155679349 @default.
• W2084009328 cites W2163014310 @default.
• W2084009328 cites W3147894994 @default.
• W2084009328 cites W4236448925 @default.
• W2084009328 cites W4293241248 @default.
• W2084009328 cites W4377889779 @default.
• W2084009328 doi "https://doi.org/10.1200/jco.2003.04.057" @default.
• W2084009328 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12610188" @default.
• W2084009328 hasPublicationYear "2003" @default.
• W2084009328 type Work @default.
• W2084009328 sameAs 2084009328 @default.
• W2084009328 citedByCount "36" @default.
• W2084009328 countsByYear W20840093282012 @default.
• W2084009328 countsByYear W20840093282015 @default.
• W2084009328 countsByYear W20840093282016 @default.
• W2084009328 countsByYear W20840093282019 @default.
• W2084009328 countsByYear W20840093282022 @default.
• W2084009328 crossrefType "journal-article" @default.
• W2084009328 hasAuthorship W2084009328A5002347804 @default.
• W2084009328 hasAuthorship W2084009328A5006101210 @default.
• W2084009328 hasAuthorship W2084009328A5008820123 @default.
• W2084009328 hasAuthorship W2084009328A5009102500 @default.
• W2084009328 hasAuthorship W2084009328A5027897588 @default.
• W2084009328 hasAuthorship W2084009328A5045807201 @default.
• W2084009328 hasAuthorship W2084009328A5066408904 @default.
• W2084009328 hasAuthorship W2084009328A5079982147 @default.
• W2084009328 hasConcept C121608353 @default.
• W2084009328 hasConcept C126322002 @default.
• W2084009328 hasConcept C126894567 @default.
• W2084009328 hasConcept C141071460 @default.
• W2084009328 hasConcept C143998085 @default.
• W2084009328 hasConcept C16005928 @default.
• W2084009328 hasConcept C168563851 @default.
• W2084009328 hasConcept C203092338 @default.
• W2084009328 hasConcept C2776235491 @default.
• W2084009328 hasConcept C2779548794 @default.
• W2084009328 hasConcept C2780192828 @default.
• W2084009328 hasConcept C2780201970 @default.
• W2084009328 hasConcept C2781064554 @default.
• W2084009328 hasConcept C2781190966 @default.
• W2084009328 hasConcept C2994223898 @default.
• W2084009328 hasConcept C71924100 @default.
• W2084009328 hasConceptScore W2084009328C121608353 @default.
• W2084009328 hasConceptScore W2084009328C126322002 @default.
• W2084009328 hasConceptScore W2084009328C126894567 @default.
• W2084009328 hasConceptScore W2084009328C141071460 @default.
• W2084009328 hasConceptScore W2084009328C143998085 @default.
• W2084009328 hasConceptScore W2084009328C16005928 @default.
• W2084009328 hasConceptScore W2084009328C168563851 @default.
• W2084009328 hasConceptScore W2084009328C203092338 @default.
• W2084009328 hasConceptScore W2084009328C2776235491 @default.
• W2084009328 hasConceptScore W2084009328C2779548794 @default.
• W2084009328 hasConceptScore W2084009328C2780192828 @default.
• W2084009328 hasConceptScore W2084009328C2780201970 @default.
• W2084009328 hasConceptScore W2084009328C2781064554 @default.
• W2084009328 hasConceptScore W2084009328C2781190966 @default.
• W2084009328 hasConceptScore W2084009328C2994223898 @default.
• W2084009328 hasConceptScore W2084009328C71924100 @default.
• W2084009328 hasIssue "5" @default.
• W2084009328 hasLocation W20840093281 @default.
• W2084009328 hasLocation W20840093282 @default.
• W2084009328 hasOpenAccess W2084009328 @default.
• W2084009328 hasPrimaryLocation W20840093281 @default.
• W2084009328 hasRelatedWork W1966846135 @default.
• W2084009328 hasRelatedWork W1988406497 @default.
• W2084009328 hasRelatedWork W2010765098 @default.
• W2084009328 hasRelatedWork W2094570582 @default.
• W2084009328 hasRelatedWork W2155169688 @default.
• W2084009328 hasRelatedWork W2338595158 @default.
• W2084009328 hasRelatedWork W2395356090 @default.
• W2084009328 hasRelatedWork W2588988563 @default.
• W2084009328 hasRelatedWork W2735900144 @default.
• W2084009328 hasRelatedWork W4236858530 @default.
• W2084009328 hasVolume "21" @default.
• W2084009328 isParatext "false" @default.
• W2084009328 isRetracted "false" @default.

• next